Monday, November 9, 2026

Albert Einstein Letters Warning About Danger of Atomic Bomb and Power-hungry Leaders go to Auction

Letters by Albert Einstein warning about nuclear weapons and power-hungry leaders went up for auction in Jerusalem. In one letter written seven months before Hiroshima, Einstein foresaw atomic weapons deciding the war.

LM Salvado
LM Salvado

June 8, 2018

18 February 1949 letter. Einstein reply to Dr Alton R. Chapple.
JERUSALEM, Israel (ViaNews) - Several letters written by Albert Einstein are on sale by an auction house based in Jerusalem, Israel. In one of those letters, written seven months prior to the first atomic bombing attack in history, Einstein foresees that a nuclear weapon will decide the fate of war. In another letter, Albert Einstein warns that without a supranational authority, the next world war is just around the corner.

Einstein predicts how the war will end

On January 18, 1945, Einstein writes a response to Dr Held predicting that the use of atomic weaponry will decide World War II. Einstein's prediction was accurate. The bombing of Hiroshima and Nagasaki on the 6th and 9th of August 1945 did, in fact, end the war. At the beginning of his letter, Einstein warns Dr Held (who was apparently opposed to the establishment of a supranational authority) that it's forbidden to stop halfway. According to Einstein, If this type of authority is not established, the next world war will definitely erupt. This letter is presently offered for auction with an opening price of $6000 and an estimated sale price of around $20,000. [caption id="attachment_4333" align="aligncenter" width="696"]18 February 1949 letter. Einstein reply to Dr Alton R. Chapple. 18 February 1949 letter. Einstein reply to Dr Alton R. Chapple.[/caption]

Einstein believes that power-hungry leaders will lead to more war and atomic bomb attacks

A more lengthy letter is addressed to Australian pathologist, Dr Alton R. Chapple on 18 February 1949. Einstein analyzes the reasons why it's impossible to prevent the world from using and continuing to develop ammunition for mass destruction. Einstein draws a depressing picture of a world controlled by unrestrained people motivated by their lust for power and control. These people lead the public to doom, due to their need for weapons of mass destruction. According to the same letter, philosophers and thinkers cannot prevent the future development of this type of ammunition for three reasons: 1. There are already sufficient known means for mass destruction. 2. Scientists are continually advancing scientific research, it is impossible to know in advance what application may come of their discoveries. 3. There will always be people so depressed economically that they are led to participate in the development and production of weapons of mass destruction, even if it were clear to them that their work would lead to disaster on a worldwide scale. Einstein lays his faith on the intellectual and moral autonomy of groups and people bold enough to hold to their values in all situations. This letter is mentioned in the book, Einstein on Peace, by Otto Nathan and Heinz Norden. This Einstein letter is presently being auctioned with an opening price of $8000 and an estimated sale price of around $20,000. [caption id="attachment_4335" align="aligncenter" width="696"]January 18, 1945 letter, Einstein writes a response to Dr Held. January 18, 1945 letter, Einstein writes a response to Dr Held.[/caption] At a time when leaders, such as US President Donald Trump, need to negotiate nuclear deals and sanctions, will Einstein foresight continue to be meaningful going forward?

This report was co-written by Avi Blumenthal.

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com